Our data did not demonstrate any statistically significant correlation between RAD51 polymorphisms and the risk factors for endometrial cancer, such as BMI (body mass index), HRT (hormone replacement therapy), uterine bleeding, endometrial transvaginal ultrasound, diabetes and hypertension and women with endometrial cancer, here again erase the remark “(data not shown)”. The gene discussed is RAD51; the disease is endometrial cancer.